The influence of comorbid conditions on the safety profile of infliximab treatment in Japanese patients with rheumatoid arthritis: The post-marketing surveillance trial.

被引：0
|
作者：
Yano, Toshiro
Togo, Masanori
Nogami, Yoshihide
Takeuchi, Tsutomu
Koike, Takao
机构：
[1] Tanabe Seiyaku Co Ltd, Osaka, Japan
[2] Saitama Med Ctr, Dept Internal Med 2, Kawagoe, Saitama, Japan
[3] Hokkaido Univ, Grad Sch Med, Dept Med 2, Sapporo, Hokkaido, Japan
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S426 / S426
页数：1
相关论文
共 50 条
  • [31] Infection Events in Japanese Patients with Rheumatoid Arthritis Treated with Tofacitinib: Interim All-Case Post-Marketing Surveillance
    Tamura, Naoto
    Kuwana, Masataka
    Atsumi, Tatsuya
    Takei, Syuji
    Harigai, Masayoshi
    Fujii, Takao
    Matsuno, Hiroaki
    Mimori, Tsuneyo
    Momohara, Shigeki
    Yamamoto, Kazuhiko
    Takasaki, Yoshinari
    Nomura, Kazuto
    Endo, Yutaka
    Hirose, Tomohiro
    Morishima, Yosuke
    Sugiyama, Naonobu
    Yoshii, Noritoshi
    Takagi, Michiaki
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [32] 24-week, Post-Marketing Surveillance Analysis of Upadacitinib in Japanese Patients with Rheumatoid Arthritis (Encore1)
    Atsumi, Tatsuya
    Okamoto, Nami
    Takahashi, Nobunori
    Tamura, Naoto
    Nakajima, Atsuo
    Nakajima, Ayako
    Fujii, Takao
    Matsuno, Hiroaki
    Kawaberi, Takeshi
    Sunaga, Naomi
    Tsujita, Yuki
    Chonan, Sumi
    Kuwana, Masataka
    Takagi, Michiaki
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4281 - 4283
  • [33] 24-week, Post-Marketing Surveillance Analysis of Upadacitinib in Japanese Patients with Rheumatoid Arthritis: The 2024 Interim Report
    Fujii, Takao
    Okamoto, Nami
    Abe, Asami
    Takagi, Michiaki
    Takahashi, Nobunori
    Nakajima, Atsuo
    Nakajima, Ayako
    Nakayamada, Shingo
    Nishida, Keiichiro
    Kawaberi, Takeshi
    Sunaga, Naomi
    Tsujita, Yuki
    Chonan, Sumi
    Kuwana, Masataka
    Tanaka, Yoshiya
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1026 - 1029
  • [34] Malignancy in Japanese Patients with Rheumatoid Arthritis Treated with Tofacitinib: Interim Analysis of All-Case Post-Marketing Surveillance
    Tamura, Naoto
    Kuwana, Masataka
    Atsumi, Tatsuya
    Takei, Syuji
    Harigai, Masayoshi
    Fujii, Takao
    Matsuno, Hiroaki
    Mimori, Tsuneyo
    Momohara, Shigeki
    Yamamoto, Kazuhiko
    Takasaki, Yoshinari
    Nomura, Kazuto
    Endo, Yutaka
    Hirose, Tomohiro
    Morishima, Yosuke
    Sugiyama, Naonobu
    Yoshii, Noritoshi
    Takagi, Michiaki
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [35] Safety, efficacy, and drug survival of the infliximab biosimilar CT-P13 in post-marketing surveillance of Japanese patients with psoriasis
    Morita, Akimichi
    Nishikawa, Kiyohiro
    Yamada, Fumika
    Yamanaka, Keiichi
    Nakajima, Hideki
    Ohtsuki, Mamitaro
    JOURNAL OF DERMATOLOGY, 2022, 49 (10): : 957 - 969
  • [36] Safety and effectiveness of bevacizumab in Japanese patients with malignant glioma: a post-marketing surveillance study
    Motoo, Nagane
    Hayashi, Yasuko
    Shimizu, Ayaka
    Ura, Masako
    Nishikawa, Ryo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (11) : 1016 - 1023
  • [37] Post-Marketing Surveillance of the Safety and Effectiveness of Emicizumab in Japanese Patients with Congenital Hemophilia A with Inhibitors
    Shima, Midori
    Fukutake, Katsuyuki
    Matsumoto, Masanori
    Sugimura, Yoshihiko
    Sugita, Chiaki
    Ji, Lyu
    Kawano, Mika
    Matsushita, Tadashi
    BLOOD, 2024, 144 : 2583 - 2584
  • [38] Correction to: Effect of Golimumab Dose Escalation in Japanese Patients With Rheumatoid Arthritis: Post-Hoc Analysis of Post-Marketing Surveillance Data
    Hirohito Shimizu
    Hisanori Kobayashi
    Masayoshi Kanbori
    Yutaka Ishii
    Rheumatology and Therapy, 2020, 7 : 1053 - 1053
  • [39] Safety and effectiveness of lenalidomide in Japanese patients with relapsed/refractory ATLL: post-marketing surveillance
    Miyazaki, Tohru
    Uno, Shuji
    Fujimori, Hiroaki
    Motegi, Yoko
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2025, 121 (01) : 79 - 88
  • [40] SAFETY AND EFFECTIVENESS OF BEVACIZUMAB IN JAPANESE PATIENTS WITH MALIGNANT GLIOMA: POST-MARKETING SURVEILLANCE RESULTS
    Nishikawa, Ryo
    Nagane, Motoo
    Shimizu, Ayaka
    Tamura, Takashi
    Ura, Masako
    NEURO-ONCOLOGY, 2017, 19 : 8 - 8
12345